content

Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222

Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health...

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on...

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to...

Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced the expansion of its global supply chain network...

Pharmaceutical Packaging And Manufacturing Trends To Be Covered By PHARMAP 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) will cover the topics of cutting-edge technologies and digitalization in the Manufacturing and Packaging processes of the...

Europital forecast 30% CAGR from UK biotech for three years

Europital โ€“ the global provider of medical management services for clinical research and drug development โ€“ announces it is opening a UK site to...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875. The First-in-Human Dose-Escalation...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read